Letter to the Editor
In a recent article, Abdelgadir et al. reported about two pediatric patients with non-mosaic trisomy 22 of whom the 5 year-old female presented with left ventricular hypertrabeculation, also known as noncompaction (LVHT). [1] We have the following comments and concerns.
Generally, LVHT is regarded as a congenital abnormality of the left ventricular myocardium characterised by a two-layered structure of the myocardium, consisting of a thin compacted outer (pericardial) and a non-compacted inner (endocardial) layer.
[2] The non-compacted layer is characterised by a complex interwoven meshwork of trabeculations, which are separated by deep intertrabecular recesses reaching the compacted layer. LVHT is most frequently located in the apex, and the lateral wall but usually spares the septum.
[2] LVHT may be associated with other cardiac abnormalities (non-isolated) or may occur as the sole morphological abnormality (isolated LVHT).
[3] Isolated and non-isolated LVHT are frequently associated with ventricular arrhythmias or systolic dysfunction. [3] There are also indications that the frequency of stroke or embolism is increased in LVHT due to thrombus formation within the intertrabecular spaces. [2, 3] In the vast majority of the cases LVHT is assumed to be present already at birth but no systematic studies on the prevalence of LVHT in early infancy have been carried out so far.
In the abstract Abdelgadir et al. claim that their report is the first one about a patient with trisomy 22 and LVHT. However, LVHT has been previously described in trisomy 22. [4] In an unborn girl with trisomy 22 Wang et al. Postnatal transthoracic echocardiography surprisingly revealed LVHT associated with a large atrial septal defect, persistent ductus arteriosus, and moderate tricuspid regurgitation. Comparison between fetal and neonatal echocardiographies suggests that LVHT in the presented patient was acquired. Acquired LVHT has been only rarely described and is associated with neuromuscular disorders (NMDs).
[5 ] To exclude that LVHT was missed on fetal intrauterine echocardiography or hidden during gestation and unmasked during delivery or shortly afterwards, the intrauterine examination should be reviewed. If LVHT is truly absent on this initial examination, the authors should provide an explanation why LVHT developed between the intrauterine echocardiography and the neonatal examination. Isolated LVHT with normal systolic function was still present at age 1y.
In addition to chromosomal abnormalities LVHT is frequently associated with NMDs.
[5] Was there any indication for a second trouble such as a NMD in the presented patient? Was the family history positive for NMD? Which were the CK levels and was an electromyogram recorded?
Overall, it should be emphasised that the presented patient had acquired LVHT, that it is not the first report of a patient with trisomy 22 and LVHT, that investigations for NMD should be initiated, and that the patient requires close follow-up to prevent systolic dysfunction or severe arrhythmias.
